ALTEOGEN revenue and financials

196170 · KRX · KRW

₩262,000.00Change from previous close: +0.77%Absolute change: +₩2,000.00

Close · October 7, 2026

In the fiscal year ended December 2025, ALTEOGEN reported revenue of ₩215.86B (+109.87% year over year). Net income was ₩141.67B, a net margin of 65.6%.

Annual revenue · 2025: ₩215.86B
  1. ₩28.81B2022
  2. ₩96.52B2023
  3. ₩102.85B2024
  4. ₩215.86B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+109.87%
2025 vs 2024
Net income growth
+127.57%
2025 vs 2024
Net margin
65.6%
2024: 60.5%

Financial data

Amounts in millions of KRW; per-share values in KRW; shares in millions.

Cash flow · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Operating cash flow16,56120,99065,023-4,88068,802—
Depreciation and amortization—2,8982,8011,360669659
Capital expenditure-2,577-14,210-15,953-7,932-5,483—
Investing cash flow40,187-45,527-48,712-10,402-49,576—
Financing cash flow-18,245-97.9-85.22,475-151—
Share repurchases——-0.00.0-1.6-1,365
Debt repaid——0.00.0——
Effect of exchange rates-409530-1,560636-332—
Net change in cash38,503-24,63516,226-12,80719,076—
Free cash flow13,9846,78149,070-12,81263,320—